Retatrutide is a legal, clinically appropriate medication that providers can prescribe if they determine a patient is a qualified candidate and the patient provides informed consent, understanding it is not FDA approved and still in clinical trials. Healthaide keeps Retatrutide off front facing websites and behind the patient portal paywall as a strategic decision to avoid potential controversy during the medication's ongoing patent review. Inside the portal it can be referred to as GLP-3 or Retatrutide interchangeably. Patients can access it through their portal or by being added manually. Whether to put it on your front facing site is your decision, but it is advised against.
retatrutideglp-3
